Archive - February 2018
Healthcare startups are flush with cash, but investors are starting to worry
NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma
EU approves Novo’s once-weekly diabetes therapy
NICE backs EUSA’s kidney cancer drug Fotivda
Boehringer abandons PDE-targeted Alzheimer’s drug
Liverpool Uni researchers given £1.5m for pancreatic cancer study
Boehringer ends development of Alzheimer’s candidate
Kentucky hopes website will track Medicaid work requirements